Showing results (441-450 of 629) with videos related to
Sort By:
Pageof 63
European Journal of Clinical Investigation|January 22, 2003
Basal TSH levels compared with TRH-stimulated TSH levels to diagnose different degrees of TSH suppression: diagnostic and therapeutic impact of assay performanceM Christ-Crain, C Meier, C-B Roth, et al.Geburtshilfe Und Frauenheilkunde|March 1, 1995
[Obstetric prognostic factors of newborn infants with very low birth weight (< or = 1,500 gram) with reference to survival rate and early childhood development]W Hamm, U J Göhring, M Günther, et al.Toxicon : Official Journal of the International Society on Toxinology|October 2, 2007
Fate and distribution of brevetoxin (PbTx) following lysis of Karenia brevis by algicidal bacteria, including analysis of open A-ring derivativesPatricia B Roth, Michael J Twiner, Zhihong Wang, et al.Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|November 1, 1992
Comparison of mother's occupation and industry from the birth certificate and a self-administered questionnaireE G Marshall, L J Gensburg, G B Roth, et al.Ophthalmology. Retina|August 16, 2023
The 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: Intraocular Pressure-Related Effects over 36 MonthsDaniel B Roth, David Eichenbaum, Deepika Malik, et al.Journal of Substance Use and Addiction Treatment|March 17, 2024
Examining the association of rurality with opioid-related morbidity and mortality in Georgia: A geospatial analysisKimberly B Roth, Dana K Goplerud, Jennifer S Babjak, et al.The British Journal of Psychiatry : the Journal of Mental Science|May 9, 2015
Psychotic experiences and risk of death in the general population: 24-27 year follow-up of the Epidemiologic Catchment Area studyVandad Sharifi, William W Eaton, Li Tzy Wu, et al.Retina (Philadelphia, Pa.)|October 6, 2005
Intravitreal triamcinolone acetonide for diabetic macular edemaJanet J Chieh, Daniel B Roth, Mimi Liu, et al.Ophthalmology. Retina|May 4, 2019
Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic RetinopathyCharles C Wykoff, David A Eichenbaum, Daniel B Roth, et al.Proceedings. AMIA Symposium|February 5, 2002
Developing a taxonomy for research in adverse drug events: potholes and signpostsJ R Nebeker, J F Hurdle, J Hoffman, et al.Pageof 63